Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Integra LifeSciences Holdings Corporation (IART : NSDQ)

• Company Description    Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra's orthopedic products include devices and implants for foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. Surgeons don't have a minute to waste. They navigate a world of uncertainty while making thousands of decisions every day. These decisions directly affect patients - and surgeons. Number of Employees: 3,800

• Price / Volume Information    Yesterday's Closing Price: $59.90 Daily Weekly Monthly 20 Day Moving Average: 495,146 shares Shares Outstanding: 83.14 (millions) Market Capitalization: $4,979.79 (millions) Beta: 1.10 52 Week High: $76.70 52 Week Low: $55.18 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -6.27% 5.55% 12 Week -9.16% -0.14% Year To Date -10.58% 8.83%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1100 CAMPUS ROAD - PRINCETON,NJ 08540 USA ph: 609-275-0500 fax: 609-750-4277 michael.beaulieu@integralife.com http://www.integralife.com

• General Corporate Information    Officers Jan De Witte - President and Chief Executive Officer Stuart M. Essig - Chairman of the Board Carrie L. Anderson - Executive Vice President and Chief Financial Offic Jeffrey A. Mosebrook - Senior Vice President; Finance Rhonda Germany Ballintyn - Director Peer Information Integra LifeSciences Holdings Corporation (ABMD) Integra LifeSciences Holdings Corporation (DMDS) Integra LifeSciences Holdings Corporation (CPWY.) Integra LifeSciences Holdings Corporation (EQUR) Integra LifeSciences Holdings Corporation (ECIA) Integra LifeSciences Holdings Corporation (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 457985208 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 07/27/22 Share - Related Items Shares Outstanding: 83.14 Most Recent Split Date: 1.00 (2.00:1) Beta: 1.10 Market Capitalization: $4,979.79 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.80 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.31 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 9.60% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/27/22

• Fundamental Ratios P/E Current FY Estimate: 18.10 Trailing 12 Months: 18.54 PEG Ratio: 1.89 Price Ratios Price/Book: 3.08 Price/Cash Flow: 12.73 Price / Sales: 3.19 EPS Growth vs. Year Ago Period: 7.25% vs. Previous Quarter: -11.90% Sales Growth vs. Year Ago Period: 4.60% vs. Previous Quarter: -7.12% ROE 03/31/22 - 16.88 12/31/21 - 16.93 09/30/21 - 17.33 ROA 03/31/22 - 7.35 12/31/21 - 7.24 09/30/21 - 7.30 Current Ratio 03/31/22 - 3.38 12/31/21 - 3.39 09/30/21 - 3.32 Quick Ratio 03/31/22 - 2.34 12/31/21 - 2.46 09/30/21 - 2.33 Operating Margin 03/31/22 - 17.62 12/31/21 - 17.61 09/30/21 - 17.75 Net Margin 03/31/22 - 10.04 12/31/21 - 10.96 09/30/21 - 14.19 Pre-Tax Margin 03/31/22 - 11.98 12/31/21 - 13.92 09/30/21 - 13.23 Book Value 03/31/22 - 19.43 12/31/21 - 19.89 09/30/21 - 19.26 Inventory Turnover 03/31/22 - 1.83 12/31/21 - 1.84 09/30/21 - 1.83 Debt-to-Equity 03/31/22 - 0.93 12/31/21 - 0.89 09/30/21 - 0.92 Debt-to-Capital 03/31/22 - 48.18 12/31/21 - 47.12 09/30/21 - 47.88

Powered by Zacks Investment Research ©